Hepatic hydrothorax: current approaches to diagnosis and therapy
Hepatic hydrothorax (HH) is a troublesome pulmonary complication that can arise in end-stage liver disease patients and can significantly impair patient quality of life and functional ability. The presence of portal hypertension, the accumulation of ascites, and subsequent fluid translocation through diaphragmatic fenestrations underlies this complication. Other pleural effusion etiologies must be excluded to ensure alternative diagnoses are not the pleural effusion source. Once attributed to HH, management and an optimal patient outcome can be difficult to achieve. This review will discuss the current understanding and various approaches to HH management, with a focus on intrathoracic interventions for this vexing clinical problem.
aDivision of Pulmonary, Allergy, and Critical Care, Section of Interventional Pulmonology and Thoracic Oncology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
Address reprint requests to Andrew R. Haas, MD, PhD, Section of Interventional Pulmonary and Thoracic Oncology, University of Pennsylvania Medical Center, Division of Pulmonary, Allergy, and Critical Care, 823 West Gates Building, 3400 Spruce Street, Philadelphia, PA 19104
The authors report no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.